Anan Kuna iya ganin Jerin Manyan Kamfanonin Magunguna guda 10 a Duniya. Duniya kasuwar hada magunguna ana tsammanin yayi girma a cikin adadin shekara-shekara na 3-6% a cikin shekaru masu zuwa, tare da kashe kuɗin kulawa na musamman ya kai 50% nan da 2023 a yawancin kasuwannin da suka ci gaba.
Ga jerin Manyan Kamfanonin Magunguna 10 a Duniya.
Jerin Manyan Kamfanonin Magunguna 10 a Duniya
don haka ga jerin manyan kamfanoni 10 na Magunguna a Duniya. Kamfanonin harhada magunguna sun jera ta hannun kasuwar magunguna.
10. Sanofi
Sanofi jagora ne na kiwon lafiya na duniya kuma daya daga cikin mafi kyawun kamfanonin harhada magunguna. Kamfanin Kulawa na Farko da Kulawa na Musamman GBUs an mayar da hankali ne kawai akan manyan kasuwanni. Alamar tana cikin manyan kamfanonin harhada magunguna 20 na duniya.
Sanofi's Vaccines GBU yana da ƙware mai ƙarfi akan mura, polio/pertussis/Hib, boosters da meningitis. Bututunsa ya haɗa da ɗan takarar rigakafin ƙwayar cuta na syncytial na numfashi wanda zai iya haifar da cututtukan huhu mai tsanani a cikin yara.
- Canji: $42 biliyan
The Consumer Healthcare GBU tana ba da hanyoyin kulawa da kai a manyan nau'ikan guda huɗu: rashin lafiyan, tari da sanyi; zafi; lafiyar narkewa; da abinci mai gina jiki. Kamfanin yana cikin manyan samfuran magunguna na duniya.
9. GlaxoSmithKline plc girma
Kamfanin yana da kasuwancin duniya guda uku waɗanda ke gano, haɓakawa da kera sabbin magunguna, alluran rigakafi da samfuran lafiyar masu amfani. Kowace rana, alamar tana taimakawa inganta lafiyar miliyoyin mutane a duniya. Ɗaya daga cikin manyan kamfanonin harhada magunguna na oncology 10.
- Canji: $43 biliyan
Kasuwancin Pharmaceuticals na kamfanin yana da fa'ida mai fa'ida na sabbin abubuwa da
kafa magunguna a cikin numfashi, HIV, immuno-kumburi da oncology.
Alamar tana ƙarfafa bututun R&D ta hanyar mai da hankali kan rigakafi, ɗan adam
kwayoyin halitta da fasahar zamani don taimaka mana gano sabbin magunguna masu canza canji ga marasa lafiya.
GSK shine kamfani mafi girma na alluran rigakafi ta hanyar kudaden shiga, yana ba da alluran rigakafi
wanda ke kare mutane a kowane mataki na rayuwa. Kamfanin R&D yana mai da hankali kan haɓakawa
alluran rigakafin cututtuka masu yaduwa waɗanda ke haɗa babban buƙatun likita da ƙarfin kasuwa mai ƙarfi.
8. Merck
Shekaru 130, Merck (wanda aka sani da MSD a wajen Amurka da Canada) ya kasance yana ƙirƙira don rayuwa, yana kawo magunguna da alluran rigakafi ga yawancin cututtukan da suka fi ƙalubalanci a duniya don cimma manufarmu ta ceto da inganta rayuka. Kamfanin na 8 mafi girma a cikin jerin Manyan Kamfanonin Magunguna 10.
- Canji: $47 biliyan
Kamfanin yana fatan zama babban kamfani na bincike mai zurfi a cikin duniya kuma mafi kyawun kamfanonin harhada magunguna. Alamar tana nuna sadaukarwa ga marasa lafiya da lafiyar jama'a ta hanyar haɓaka damar samun kulawar lafiya ta hanyar manufofi masu nisa, shirye-shirye da haɗin gwiwa.
A yau, alamar ta ci gaba da kasancewa kan gaba wajen bincike don rigakafi da magance cututtuka da ke barazana ga mutane da dabbobi - ciki har da ciwon daji, cututtuka masu yaduwa, irin su HIV da Ebola, da cututtukan dabbobi masu tasowa.
7. Novartis
Ofaya daga cikin Manyan Kamfanonin Magunguna na 10 Novartis Pharmaceuticals suna kawo sabbin magunguna zuwa kasuwa don haɓaka sakamakon kiwon lafiya ga marasa lafiya da ba da mafita ga masu ba da lafiya waɗanda ke kula da su. Novartis yana kan gaba a cikin jerin kamfanonin harhada magunguna.
- Canji: $50 biliyan
AveXis yanzu Novartis Gene Therapies ne. Novartis Gene Therapies an sadaukar da shi don haɓakawa da kuma tallata hanyoyin maganin ƙwayoyin cuta ga marasa lafiya da iyalai waɗanda ba su da yawa kuma masu barazanar rayuwa ta cututtukan ƙwayoyin cuta. Novartis ita ce ta 7 a cikin jerin manyan kamfanonin harhada magunguna 20 na duniya.
6. Pfizer
Kamfanin yana amfani da ilimin kimiyya da albarkatun duniya don kawo hanyoyin kwantar da hankali ga mutanen da ke haɓakawa da inganta rayuwarsu ta hanyar ganowa, haɓakawa, ƙira da rarraba samfuran kiwon lafiya, gami da sabbin magunguna da alluran rigakafi.
- Canji: $52 biliyan
Kamfanin yana aiki a cikin kasuwannin da suka ci gaba da haɓaka don haɓaka lafiya, rigakafi, jiyya da warkarwa waɗanda ke ƙalubalantar cututtukan da ake jin tsoro na lokaci. Pfizer ita ce ta 6 a jerin manyan kamfanonin harhada magunguna 20 na duniya.
Alamar tana haɗin gwiwa tare da masu ba da kiwon lafiya, gwamnatoci da al'ummomin gida don tallafawa da faɗaɗa samun abin dogaro, ingantaccen kiwon lafiya a duniya. Kamfanin yana cikin manyan samfuran magunguna na duniya.
5. Bayer
Ƙungiyar Bayer ana gudanar da ita a matsayin kamfanin kimiyyar rayuwa tare da sassa uku - Pharmaceuticals, Lafiyar Mabukaci da Kimiyyar amfanin gona, waɗanda kuma ke ba da rahoto. Ayyukan Ƙaddamarwa suna tallafawa kasuwancin aiki. A cikin 2019, Ƙungiyar Bayer ta ƙunshi kamfanoni 392 masu haɗin gwiwa a cikin ƙasashe 87.
- Canji: $52 biliyan
Bayer wani kamfani ne na Kimiyyar Rayuwa wanda ke da tarihin sama da shekaru 150 da ƙwarewar ƙwarewa a fannonin kiwon lafiya da noma. Tare da sabbin samfura, Alamar tana ba da gudummawar nemo mafita ga wasu manyan ƙalubalen zamaninmu.
Sashen Pharmaceuticals yana mai da hankali kan samfuran magunguna, musamman don ilimin zuciya da lafiyar mata, da kuma kan hanyoyin kwantar da hankali na musamman a fannonin cututtukan daji, ilimin jini da ilimin ido.
Har ila yau, rabon ya ƙunshi kasuwancin rediyo, wanda ke sayar da kayan aikin bincike tare da ma'auni masu mahimmanci. Bayer yana cikin manyan kamfanonin harhada magunguna 10 na oncology.
Karin bayani Manyan Kamfanonin Pharma na Duniya
4. Rukunin Roche
Roche na ɗaya daga cikin kamfanoni na farko da suka kawo jiyya ga marasa lafiya da kuma mafi kyawun kamfanonin harhada magunguna. Tare da haɗin gwiwa mai ƙarfi a cikin magunguna da bincike, kamfanin ya fi kowane kamfani kayan aiki don haɓaka keɓaɓɓen kiwon lafiya. Na 4 mafi girma a cikin jerin Manyan Kamfanonin Magunguna 10.
- Canji: $63 biliyan
Kashi biyu bisa uku na ayyukan Bincike da haɓaka ana haɓaka su tare da gano alamun abokan hulɗa. Kamfanin ya kasance kan gaba wajen gudanar da bincike da kuma magance cutar kansa sama da shekaru 50, tare da magungunan nono, fata, hanji, ovarian, huhu da sauran cututtuka masu yawa. Kamfanin yana cikin manyan samfuran magunguna na duniya.
Alamar ita ce lamba 1 a duniya a fannin kimiyyar halittu tare da magunguna 17 na biopharmaceutical a kasuwa. Fiye da rabin mahadi a cikin bututun samfur sune biopharmaceuticals, suna ba mu damar isar da ingantattun hanyoyin kwantar da hankali. Kamfanin yana cikin jerin Manyan Kamfanonin Magunguna guda 10.
3. Sinopharm
China National Pharmaceutical Group Co., Ltd. (Sinopharm) babban rukunin kiwon lafiya ne kai tsaye a ƙarƙashin mallakar Jiha Kadarorin Hukumar Kula da Gudanarwa (SASAC) na Majalisar Jiha, tare da 128,000 ma'aikata da cikakken sarkar a cikin masana'antar da ke rufe R&D, masana'anta, dabaru da rarrabawa, retail sarƙoƙi, kiwon lafiya, aikin injiniya, nune-nunen da taro, kasuwancin duniya da sabis na kuɗi.
Sinopharm ta mallaki fiye da rassa 1,100 da kamfanoni 6 da aka jera. Sinopharm ya gina hanyar sadarwa ta ƙasa da rarraba don magunguna da na'urorin likitanci da kayan aiki, gami da cibiyoyin dabaru 5, fiye da cibiyoyin matakin lardi 40 da kuma wuraren aikin matakan matakin birni sama da 240.
- Canji: $71 biliyan
Ta hanyar kafa tsarin sabis na kiwon lafiya mai wayo, Sinopharm tana ba da ingantattun ayyuka ga abokan cinikin kamfanoni sama da 230,000. Sinopharm tana da cibiyar bincike kan harhada magunguna da kuma cibiyar tsara aikin injiniya, dukkansu suna kan gaba a kasar Sin.
Masana kimiyya biyu na Kwalejin Injiniya ta kasar Sin, da cibiyoyin R&D na kasa 11, da cibiyoyin fasaha na larduna 44, da masana kimiyya sama da 5,000 sun samu gagarumar nasara. Kamfanin yana ɗaya daga cikin mafi kyawun kamfanonin harhada magunguna.
Har ila yau, Sinopharm ya jagoranci kafa sama da sharuddan fasaha na kasa 530, daga cikinsu rigakafin EV71, sabon nau'in sabon nau'in magani na kasar Sin tare da Sinopharm mai cikakken ikon mallakar fasaha mai zaman kansa, yana rage cutar cututtukan kafa da baki a tsakanin yaran Sinawa. R&D da ƙaddamar da sIPV suna tabbatar da ci gaban shirin rigakafin cutar shan inna na ƙasa.
2. Johnson & Johnson
Johnson & Johnson da rassan sa (Kamfanin) suna da kusan ma'aikata 132,200 a duk duniya waɗanda ke yin bincike da haɓakawa, ƙira da siyar da samfuran samfuran da yawa a fagen kiwon lafiya. Na biyu a cikin jerin Manyan Kamfanonin Magunguna guda 2
- Canji: $82 biliyan
Johnson & Johnson kamfani ne mai rikewa, tare da kamfanoni masu gudanar da kasuwanci a kusan dukkanin kasashen duniya. Babban fifikon Kamfanin shine samfuran da suka shafi lafiyar ɗan adam da jin daɗin rayuwa. An haɗa Johnson & Johnson a cikin Jihar New Jersey a cikin 1887.
Yana ɗaya daga cikin manyan kamfanonin harhada magunguna na oncology 10. Kamfanin yana gabatarwa a cikin sassan kasuwanci guda uku: Mabukaci, Magunguna da Na'urorin Likita. Bangaren Pharmaceutical yana mai da hankali ne akan wuraren warkewa guda shida:
- Immunology (misali, rheumatoid arthritis, cututtukan hanji mai kumburi da psoriasis),
- Cututtuka masu yaduwa (misali, HIV/AIDS),
- Ilimin jijiya (misali, rashin lafiyar yanayi, cututtukan neurodegenerative da schizophrenia),
- Oncology (misali, prostate cancer da hematologic malignancies),
- Zuciya da jijiyoyin jini da narkewa (misali, thrombosis da ciwon sukari) da
- Hawan Jini (misali, Hawan Jijiyoyi na Huhu).
Ana rarraba magunguna a cikin wannan sashin kai tsaye ga dillalai, dillalai, asibitoci da ƙwararrun kiwon lafiya don amfani da magani. Kamfanin shine kamfani na biyu mafi girma a fannin harhada magunguna a duniya.
1. Albarkatun kasar Sin
China Resources (Holdings) Co., Ltd. ("CR" ko "China Resources Group") kamfani ne mai bambancin ra'ayi mai rijista a Hong Kong. An fara kafa CR a matsayin "Liow & Co." a Hong Kong a cikin 1938, kuma daga baya aka sake fasalin kuma aka sake masa suna zuwa Kamfanin Albarkatun China a 1948.
A shekarar 1952, maimakon ta kasance tana da alaka da babban ofishin kwamitin kolin JKS, sai ta koma karkashin sashen ciniki na tsakiya (wanda a yanzu ake kira ma'aikatar kasuwanci). Albarkatun kasar Sin ita ce manyan kamfanonin harhada magunguna a duniya ta hanyar kudaden shiga.
A shekarar 1983, an sake sake fasalin kasar Sin Resources (Holdings) Co., Ltd. A watan Disamba na shekarar 1999, CR ba ta da alaka da ma'aikatar cinikayya da hadin gwiwar tattalin arziki, kuma ta kasance karkashin kulawar jihohi. A cikin 2003, ƙarƙashin kulawar SASAC kai tsaye, ta zama ɗaya daga cikin manyan kamfanoni na gwamnati.
- Canji: $95 biliyan
A karkashin rukunin albarkatun kasar Sin akwai fannonin kasuwanci guda biyar, wadanda suka hada da kayayyakin masarufi, kiwon lafiya, ayyukan makamashi, gine-gine da gudanar da aiki a birane, fasaha da hada-hadar kudi, sassan kasuwanci masu mahimmanci guda bakwai, mataki na 19-1. riba cibiyoyi, kusan ƙungiyoyin kasuwanci 2,000, da ma'aikata sama da 420,000.
A Hong Kong, akwai kamfanoni bakwai da aka jera a ƙarƙashin CR, kuma CR Land yanki ne na HSI. Albarkatun kasar Sin ita ce babbar kamfanin harhada magunguna a duniya ta hannun jarin kasuwa.
Don haka a ƙarshe waɗannan sune jerin manyan kamfanonin harhada magunguna.
Na gode da raba. Zan yi ƙoƙarin aiwatar da waɗannan hanyoyin akan blog na. Na gode da raba. Ci gaba da sabunta mu.
Babban rubutun bulogi. Nasiha masu taimako da fadakarwa. Ina son shi godiya don raba wannan bayanin tare da mu